Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A dominant role for glucose in β cell compensation of insulin resistance
Gordon C. Weir, Susan Bonner-Weir
Gordon C. Weir, Susan Bonner-Weir
Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):81-83. https://doi.org/10.1172/JCI30862.
View: Text | PDF
Commentary Article has an altmetric score of 4

A dominant role for glucose in β cell compensation of insulin resistance

  • Text
  • PDF
Abstract

Increased insulin secretion and expansion of pancreatic β cell mass work together to maintain normal glucose levels when insulin resistance develops. Changes in glucose concentration have long been known to have profound effects upon the rates of insulin secretion and β cell mass, but various other agents can also cause changes, raising questions about which mechanisms are dominant. Evidence favoring a dominant role for glucose is provided by Terauchi et al. in this issue of the JCI (see the related article beginning on page 246). Mice haploinsufficient for β cell glucokinase (Gck) were unable to increase their β cell mass in response to insulin resistance produced by high-fat feeding. Gck is known to be the glucose sensor for glucose metabolism in β cells. The study also provides strong evidence that insulin receptor substrate 2 (Irs2), which is known to have major effects on β cell growth and survival, is a key downstream mediator of the effects of glucose found in this study.

Authors

Gordon C. Weir, Susan Bonner-Weir

×

Total citations by year

Year: 2022 2021 2020 2018 2016 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 2 2 1 1 1 4 1 4 2 1 6 4 1 30
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (4)

Title and authors Publication Year
Decreased fetal size is associated with beta-cell hyperfunction in early life and failure with age
MV Chakravarthy, Y Zhu, MB Wice, T Coleman, KL Pappan, CA Marshall, ML McDaniel, CF Semenkovich
Diabetes 2008
ICA512 signaling enhances pancreatic -cell proliferation by regulating cyclins D through STATs
H Mziaut, S Kersting, KP Knoch, WH Fan, M Trajkovski, K Erdmann, H Bergert, F Ehehalt, HD Saeger, M Solimena
Proceedings of the National Academy of Sciences 2008
Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells
N Sonoda, T Imamura, T Yoshizaki, JL Babendure, JC Lu, JM Olefsky
Proceedings of the National Academy of Sciences 2008
The Metabolic Syndrome
MA Cornier, D Dabelea, TL Hernandez, RC Lindstrom, AJ Steig, NR Stob, RE van Pelt, H Wang, RH Eckel
Endocrine reviews 2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 1 patents
62 readers on Mendeley
See more details